Morgan Stanley Expands Shareworks Stock Plan In EMEA

Morgan Stanley (MS) said Tuesday that it reached a deal to migrate the Barclays Global Stock and Rewards business to Shareworks by Morgan Stanley. The deal is expected to bring about 40 new corporate clients to Shareworks, encompassing more than 140,000 stock plan employees.

Barclays' corporate stock plan clients have already been using Shareworks' stock plan administration services platform for the past eight years through a white-label arrangement.

Morgan Stanley noted that clients will continue to be managed by their current Shareworks service and relationship management teams and will continue to benefit from the same technology platform that both companies have delivered.

Shareworks in the EMEA region provides technology and outsourced services to European issuers across both public and private markets.

Established in the UK in 2012, Shareworks in EMEA has more than 120 employees in the UK, Germany and Spain now servicing over 100 companies.

Before the migration of the Barclays stock plan business, Shareworks' EMEA client base employed more than 125,000 stock plan participants who hold more than 14 billion euros or US$16.5 billion in stock plan assets, Morgan Stanley said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
Follow RTT